How a new drug enters the body with and without acid-reducing medicine
Treatments studied
This trial tests how a study drug called florensocatib is absorbed into your blood. It compares taking the drug alone versus with a common stomach acid reducer. This helps researchers understand how to best give the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a healthy male between 18 and 65 years old
- Your body mass index (BMI) is between 18 and 30
- You weigh between 99 and 220 pounds (45 to 100 kg)
- You are a non-smoker or have smoked less than 5 pack-years in your life
- You have no major health issues and normal blood tests, heart tests, and vital signs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study tests how a new experimental drug (BMS-986533) is processed and tolerated by healthy volunteers. Researchers will also check how food and stomach acid affect the drug, and whether it interacts with other medications.
This study tests how a new drug (BMS-986435) is absorbed by the body and whether food changes that. It is for healthy volunteers to help understand the right dose for future patients.
This study tests a new medicine, CHF10196, in healthy men to see if it changes how the body handles two common drugs: a blood thinner and a cholesterol-lowering drug. This helps make sure the new medicine is safe to use with other medicines.
This trial tests how a new drug called ABSK-011 is absorbed by the body when taken with a low-fat meal, a high-fat meal, or a stomach acid medicine. Healthy volunteers are needed to help understand these effects.
This study tests how a new experimental drug (VRN101099) works in your body when taken with food and with a common stomach acid medication. Researchers want to understand how these factors change how much drug reaches your bloodstream, which helps them figure out the right dose for future patients.
This trial tests if a new stomach acid medicine (Zastaprazan) affects how well clopidogrel works in heart patients who have had a stent placed. It aims to help people who need both clopidogrel and a stomach acid drug after a procedure.
Hear when a new Healthy Volunteers trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.